X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1945) 1945
Publication (134) 134
Newsletter (54) 54
Book Review (27) 27
Newspaper Article (10) 10
Magazine Article (7) 7
Book Chapter (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1516) 1516
mesalamine (1081) 1081
male (948) 948
female (836) 836
colitis, ulcerative - drug therapy (807) 807
adult (735) 735
gastroenterology & hepatology (730) 730
index medicus (711) 711
mesalamine - administration & dosage (711) 711
ulcerative colitis (599) 599
mesalamine - therapeutic use (593) 593
anti-inflammatory agents, non-steroidal - administration & dosage (559) 559
middle aged (540) 540
anti-inflammatory agents, non-steroidal - therapeutic use (466) 466
inflammatory-bowel-disease (432) 432
pharmacology & pharmacy (413) 413
5-aminosalicylic acid (404) 404
treatment outcome (383) 383
administration, oral (377) 377
mesalazine (325) 325
inflammatory bowel disease (310) 310
aged (299) 299
aminosalicylic acids - administration & dosage (292) 292
mesalamine - adverse effects (267) 267
animals (259) 259
crohn disease - drug therapy (258) 258
therapy (252) 252
adolescent (244) 244
ulcerative-colitis (223) 223
anti-inflammatory agents, non-steroidal - adverse effects (214) 214
double-blind (212) 212
sulfasalazine (207) 207
crohns-disease (200) 200
aminosalicylic acids - therapeutic use (192) 192
double-blind method (185) 185
crohn's disease (178) 178
remission induction (177) 177
recurrence (174) 174
inflammatory bowel diseases - drug therapy (173) 173
remission (165) 165
time factors (163) 163
enema (161) 161
drug administration schedule (157) 157
severity of illness index (152) 152
rats (151) 151
care and treatment (146) 146
drug therapy, combination (146) 146
dose-response relationship, drug (144) 144
colitis (143) 143
drug therapy (138) 138
mesalamine - pharmacokinetics (136) 136
colon (134) 134
delayed-action preparations (134) 134
young adult (134) 134
colitis, ulcerative - pathology (131) 131
anti-inflammatory agents - therapeutic use (129) 129
mesalamine - pharmacology (127) 127
inflammatory bowel diseases (126) 126
gastroenterology (122) 122
medicine, general & internal (121) 121
anti-inflammatory agents - administration & dosage (119) 119
immunosuppressive agents - therapeutic use (118) 118
aminosalicylic acids - adverse effects (115) 115
analysis (115) 115
dosage and administration (115) 115
sulfasalazine - therapeutic use (113) 113
anti-inflammatory agents, non-steroidal - pharmacokinetics (109) 109
maintenance (109) 109
follow-up studies (108) 108
colitis, ulcerative - diagnosis (107) 107
administration, rectal (106) 106
colonoscopy (104) 104
azathioprine (101) 101
research (101) 101
colon - metabolism (100) 100
gastroenterology and hepatology (99) 99
infliximab (99) 99
prospective studies (99) 99
medicine & public health (98) 98
drug delivery systems (95) 95
inflammatory bowel-disease (92) 92
5-asa (91) 91
suppositories (90) 90
azathioprine - therapeutic use (89) 89
antifungal agents (88) 88
drugs (88) 88
management (88) 88
child (87) 87
clinical trials as topic (87) 87
mesalamine - chemistry (87) 87
aminosalicylic acids - pharmacokinetics (86) 86
colitis - drug therapy (85) 85
randomized controlled trials as topic (85) 85
risk factors (85) 85
anti-inflammatory agents, non-steroidal - pharmacology (84) 84
abridged index medicus (82) 82
gastrointestinal diseases (82) 82
proctitis (82) 82
sulfasalazine - administration & dosage (82) 82
efficacy (80) 80
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1829) 1829
German (87) 87
Japanese (33) 33
French (23) 23
Spanish (16) 16
Russian (11) 11
Danish (8) 8
Korean (8) 8
Italian (5) 5
Dutch (4) 4
Hungarian (4) 4
Chinese (3) 3
Czech (2) 2
Polish (2) 2
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2014, Volume 2014, Issue 10, p. CD006618
Background Ulcerative colitis (UC) is a chronic inflammatory bowel disease. Corticosteroids and 5‐aminosalicylates are the most commonly used therapies.... 
Colitis, Ulcerative | Mesalamine | Immunosuppressive Agents | Administration, Oral | Gastroenterology & hepatology | Induction Chemotherapy | Ulcerative colitis: induction of remission | Randomized Controlled Trials as Topic | Inflammatory bowel disease | Anti‐Inflammatory Agents | Methotrexate | Medicine General & Introductory Medical Sciences | ULCERATIVE COLITIS ‐ INDUCTION OF REMISSION | Mercaptopurine | Immunosuppressive Agents [administration & dosage; adverse effects] | 6-Mercaptopurine [administration & dosage] | Methotrexate [administration & dosage; adverse effects] | CROHNS-DISEASE | EFFICACY | Induction Chemotherapy [methods] | Humans | AZATHIOPRINE | NATIONWIDE RETROSPECTIVE COHORT | RANDOMIZED CONTROLLED-TRIAL | MEDICINE, GENERAL & INTERNAL | INFLAMMATORY-BOWEL-DISEASE | THERAPY | Anti-Inflammatory Agents [administration & dosage; adverse effects] | PHARMACOKINETICS | Colitis, Ulcerative [drug therapy] | ORAL METHOTREXATE | Mesalamine [administration & dosage] | INFLIXIMAB | Induction Chemotherapy - methods | Mercaptopurine - administration & dosage | Methotrexate - adverse effects | Anti-Inflammatory Agents - adverse effects | Anti-Inflammatory Agents - administration & dosage | Immunosuppressive Agents - adverse effects | Methotrexate - administration & dosage | Colitis, Ulcerative - drug therapy | Immunosuppressive Agents - administration & dosage | Mesalamine - administration & dosage
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2015, Volume 2015, Issue 10, p. CD007698
Background Corticosteroids are first‐line therapy for induction of remission in ulcerative colitis. Although corticosteroids may improve symptoms, they have... 
Colitis, Ulcerative | Budesonide | Mesalamine | Administration, Oral | Gastroenterology & hepatology | Anti‐Inflammatory Agents, Non‐Steroidal | Induction Chemotherapy | Ulcerative colitis: induction of remission | Prednisone | Randomized Controlled Trials as Topic | Inflammatory bowel disease | Budesonide therapy | Child health | Gastroenterology | Anti‐Inflammatory Agents | Medicine General & Introductory Medical Sciences | ULCERATIVE COLITIS ‐ INDUCTION OF REMISSION | CROHNS-DISEASE | EFFICACY | Humans | Budesonide [administration & dosage; adverse effects] | Anti-Inflammatory Agents, Non-Steroidal [administration & dosage] | Ulcerative [drug therapy] | Remission Induction | 5-AMINOSALICYLIC ACID | MAINTENANCE THERAPY | MEDICINE, GENERAL & INTERNAL | Anti-InflammatoryAgents [administration & dosage; adverse effects] | INFLAMMATORY-BOWEL-DISEASE | MILD-TO-MODERATE | EVIDENCE-BASED CONSENSUS | COLORECTAL-CANCER | POOLED ANALYSIS | MG | Colitis | Mesalamine [administration & dosage] | Prednisone - administration & dosage | Anti-Inflammatory Agents - adverse effects | Budesonide - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Induction Chemotherapy - methods | Anti-Inflammatory Agents - administration & dosage | Budesonide - administration & dosage | Colitis, Ulcerative - drug therapy | Mesalamine - administration & dosage
Journal Article
Gastroenterology, ISSN 0016-5085, 12/2018, Volume 155, Issue 6, pp. 1795 - 1804.e3
Journal Article
Environmental Health Perspectives, ISSN 0091-6765, 2/2009, Volume 117, Issue 2, pp. 185 - 189
Journal Article
Journal Article
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 5, pp. 1222 - 1230.e2
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2006, Volume 4, Issue 12, pp. 1502 - 1506
Journal Article